The global factor Xa inhibitor market is projected to see significant expansion in the coming years. This movement can be attributed to a rising prevalence of thromboembolic diseases worldwide, coupled with an senior population. , In addition, advancements in medical science have led to the manufacture of more potent factor Xa inhibitors, driving m